Xylazine Trends and Public Health Implications for Rural Communities – CEU’s

Sponsor: Center on Rural Addiction, University of Vermont

Please join us on Wednesday, June 12th from 12:00 p.m. – 1:00 p.m. ET for a UVM CORA Community Rounds Workshop Series session, “Xylazine Trends and Public Health Implications for Rural Communities.” Our speaker is Michael Chaple, PhD, Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center, and Director of the Northeast and Caribbean Rural Opioid Technical Assistance Center. This presentation will provide an overview of xylazine, current data on prevalence and other trends associated with its use, and will also discuss the public health implications associated with xylazine use. This presentation will also offer harm reduction strategies for mitigating the public health impact of xylazine. Throughout the presentation, unique implications for rural communities will be systematically addressed.

Learning objectives:

1. Describe xylazine and its inclusion as an adulterant in the drug supply

2. Discuss the public health impact of xylazine use (i.e., development of wounds, impact on overdose and overdose response, clinical implications for treatment)

3. Outline other harm reduction techniques that can address xylazine use

4. Discuss how xylazine impacts members of rural communities

Participants can expect 45 minutes of presentation followed by 15 minutes for questions and conversation. A recording of the session and slides will be shared following. Registered participants will also be added to UVM CORA’s listserv and receive notifications for future events. If you do not wish to be added, please contact us at #ob#PBEN#at#hiz.rqh#ob#.​

CME/CE Credits are available for this live webinar.​

For more information and to register click here:

Event Details

June 12, 2024
12:00 pm - 1:00 pm
via Zoom
no costs